A pH-Responsive fluorescence lifetime probe reveals GOT1 phase separation in cellular anti-senescence.
Abstract
Cellular senescence involves progressive acidification, but how cells sense and adapt to this pH shift remains unclear. Here we report that metabolic enzyme GOT1 functions as a pH sensor that undergoes liquid-liquid phase separation (LLPS) to combat senescence. Proteomic analysis identified GOT1 upregulation in aged human lung cells. Acidic conditions mimicking senescence directly induce GOT1 LLPS via its N-terminal intrinsically disordered region (IDR1), recruiting ME1 to form dynamic enzymatic co-condensates that scavenge reactive oxygen species and alleviate oxidative stress. To quantitatively interrogate GOT1's pH microenvironment during senescence, we engineered BDP-PLP, a first-in-class fluorescent probe conjugating the native GOT1 cofactor pyridoxal phosphate to a BODIPY fluorophore. Operating via a binding-inhibited PET mechanism, this probe enables high-specificity GOT1 targeting and pH-dependent fluorescence lifetime imaging (FLIM). Using FLIM, we achieved quantitative real-time visualization of pH dynamics within GOT1 condensates in living cells, revealing that phase separation generates a highly acidic local microenvironment critical for its anti-senescence function. This study uncovers a pH-triggered phase separation mechanism that bolsters antioxidant defense via metabolic enzyme co-condensation, offering new perspectives on metabolic adaptation in aging and establishing a chemical tool for probing microenvironmental dynamics.
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
GOT1 undergoes pH-triggered liquid-liquid phase separation to form condensates that scavenge ROS and alleviate oxidative stress during cellular senescence. This paper is relevant because it identifies a specific mechanistic pathway (metabolic enzyme phase separation) that cells use to adapt to the acidic microenvironment of aging, offering a potential target for intervening in the root causes of senescence rather than just treating downstream symptoms.
Author of this paper? Send a correction.